Rein Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Rein Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
RNTX | Rein Therapeutics | -$0.27 | -$0.25 | — | — | $0.00 | — | — | — | 11/13/2025 | |
RNTX | Aileron Therapeutics | -$0.45 | -$0.22 | -$0.28 | -27.27% | $0.00 | — | $0.00 | — | 08/14/2025 | |
RNTX | Rein Therapeutics | -$0.86 | — | -$0.25 | — | $0.00 | — | $0.00 | — | 05/15/2025 | |
RNTX | Rein Therapeutics | -$1.54 | — | -$1.89 | — | $0.00 | — | $0.00 | — | 04/07/2025 | |
RNTX | Rein Therapeutics | -$0.40 | -$0.41 | -$0.27 | 34.15% | $0.00 | — | $0.00 | — | 11/14/2024 | |
RNTX | Rein Therapeutics | -$0.39 | -$0.42 | -$0.45 | -7.14% | $0.00 | — | $0.00 | — | 08/14/2024 | |
RNTX | Rein Therapeutics | -$1.05 | — | -$0.86 | — | $0.00 | — | $0.00 | — | 05/15/2024 | |
RNTX | Rein Therapeutics | -$1.02 | — | -$1.54 | — | $0.00 | — | $0.00 | — | 04/15/2024 | |
RNTX | Rein Therapeutics | -$1.40 | — | -$0.40 | — | $0.00 | — | $0.00 | — | 10/13/2023 | |
RNTX | Rein Therapeutics | -$1.80 | — | -$0.39 | — | $0.00 | — | $0.00 | — | 08/11/2023 | |
RNTX | Rein Therapeutics | -$1.80 | -$0.86 | -$1.05 | -22.09% | $0.00 | — | $0.00 | — | 05/08/2023 | |
RNTX | Aileron Therapeutics | -$1.60 | -$1.36 | -$1.02 | 25.00% | $0.00 | — | $0.00 | — | 03/20/2023 | |
RNTX | Rein Therapeutics | -$1.40 | -$1.60 | -$1.40 | 12.50% | $0.00 | — | $0.00 | — | 11/01/2022 | |
RNTX | Aileron Therapeutics | -$1.20 | -$1.80 | -$1.80 | 0.00% | $0.00 | — | $0.00 | — | 08/15/2022 | |
RNTX | Aileron Therapeutics | -$1.60 | — | -$1.80 | — | $0.00 | — | $0.00 | — | 05/05/2022 | |
RNTX | Rein Therapeutics | -$24.00 | — | -$1.60 | — | $0.00 | — | $0.00 | — | 03/28/2022 | |
RNTX | Rein Therapeutics | -$2.60 | -$1.60 | -$1.40 | 12.50% | $0.00 | — | $0.00 | — | 11/12/2021 | |
RNTX | Rein Therapeutics | -$2.80 | -$1.40 | -$1.20 | 14.29% | $0.00 | — | $0.00 | — | 08/11/2021 | |
RNTX | Aileron Therapeutics | -$4.80 | -$1.40 | -$1.60 | -14.29% | $0.00 | — | $0.00 | — | 05/11/2021 | |
RNTX | Aileron Therapeutics | -$5.20 | — | -$24.00 | — | $0.00 | — | $0.00 | — | 03/24/2021 | |
RNTX | Aileron Therapeutics | -$5.60 | — | -$2.60 | — | $0.00 | — | $0.00 | — | 11/12/2020 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-14 | $-0.28 | $-0.22 | -27.3 % |
Q3 | 2024-11-14 | $-0.27 | $-0.41 | 34.2 % |
Q2 | 2024-08-14 | $-0.45 | $-0.42 | -7.14 % |
Q1 | 2023-05-08 | $-1.05 | $-0.86 | -22.1 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Está previsto que Rein Therapeutics (RNTX) presente resultados el noviembre 13, 2025. Los últimos resultados se publicaron el agosto 14, 2025 para el Q2.
El BPA real fue de $-0.28, que no alcanzó la estimación de $-0.22.
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.